MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Cash Flow Overview
Free Cash flow
-$7,555K
Unit: Thousand (K) dollars
Positive Cash Flow Breakdown
Borrowings on line of credit
Write-off of distribution agreem...
Stock-based compensation
Others
Negative Cash Flow Breakdown
Repayments on line of credit
Sales and marketing
Less cost of sales
Others
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Cash Flow
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Revenue
23,031
20,884
32,357
33,255
Less cost of sales
9,701
8,913
14,603
11,263
Gross profit
13,330
11,971
17,754
21,992
General and administrative
6,436
6,273
7,293
7,071
Sales and marketing
10,368
8,186
10,946
11,746
Research and development
695
435
459
634
Write-off of distribution agreement deposit
5,000
-
-
-
Interest expense
542
599
718
2,953
Interest income
1
219
94
-
Unrealized foreign currency translation gain
23
-1
-206
-56
Gain on divestiture
-
-
3,281
-
Other (income) expense
347
242
91
-16
Provision for income taxes
73
27
1,541
257
Net (loss) income
-9,413
-3,089
57
1,308
Depreciation and amortization
508
534
1,819
1,161
Loss (gain) on sale of fixed assets
-19
14
-267
-33
Non-cash interest
122
129
122
126
Stock-based compensation
875
746
727
641
Provision for expected credit losses
-
-
-
568
Provision for reserve on accounts receivable
283
180
1,009
-
Provision for excess and obsolete inventory
574
922
2,351
828
Gain on divestiture
-
-
3,281
-
Write-off of distribution agreement deposit
5,000
-
-
-
Other
1
2
-144
22
Accounts receivable
2,520
-444
-5,048
-1,234
Inventories
1,980
1,611
-790
1,440
Prepaid and other assets
450
-152
1,851
33
Accounts payable
668
1,641
-1,838
-399
Accrued liabilities
-995
-2,150
477
958
Net cash (used in) provided by operating activities
-7,308
-2,114
5,380
4,612
Purchases of property and equipment
247
194
395
430
Proceeds from sale of fixed assets
56
46
26
109
Distribution agreement deposit
5,000
-
-
-
Advances from pending sale of coflex/cofix assets and international hardware business
-
-
-
5,000
Proceeds from divestitures
0
10,368
10,049
-
Net cash provided by (used in) investing activities
-5,191
10,220
4,680
4,679
Borrowings on line of credit
26,265
1,630
22,493
25,761
Repayments on line of credit
14,722
12,045
22,944
26,460
Payments on long-term debt
930
2,841
3,000
5,000
Payments on financing leases
9
9
16
17
Proceeds from private placement, net of issuance costs
-
-
-65
-
Debt issuance costs
-
-
0
0
Payment of taxes from withholding of common stock on settlement of restricted stock units
46
10
10
55
Net cash used in financing activities
10,558
-13,275
-3,542
-5,771
Effect of exchange rate changes on cash and cash equivalents and restricted cash
1
-2
169
84
Net change in cash and cash equivalents and restricted cash
-1,940
-5,171
6,687
3,604
Cash and cash equivalents and restricted cash at beginning of period
12,157
17,328
10,641
6,221
Cash and cash equivalents and restricted cash at end of period
10,217
12,157
17,328
10,641
Cash and cash equivalents
9,870
-
-
-
Restricted cash
347
-
-
-
Total cash and restricted cash reported in condensed consolidated balance sheets
10,217
-
-
-
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Cash Flow
Borrowings on line of credit
$26,265K
(-49.31%↓ Y/Y)
Net cash used in
financing activities
$10,558K
(4208.17%↑ Y/Y)
Effect of exchange rate
changes on cash and cash...
$1K
(104.76%↑ Y/Y)
Canceled cashflow
$15,707K
Net change in cash
and cash...
-$1,940K
(-337.75%↓ Y/Y)
Canceled cashflow
$10,559K
Write-off of distribution
agreement deposit
$5,000K
Stock-based compensation
$875K
(-42.59%↓ Y/Y)
Accounts payable
$668K
(175.91%↑ Y/Y)
Provision for excess and
obsolete inventory
$574K
(17.14%↑ Y/Y)
Depreciation and
amortization
$508K
(-77.35%↓ Y/Y)
Provision for reserve on
accounts receivable
$283K
(-28.35%↓ Y/Y)
Non-cash interest
$122K
(-57.79%↓ Y/Y)
Loss (gain) on sale of
fixed assets
-$19K
(-138.78%↓ Y/Y)
Other
$1K
(-97.83%↓ Y/Y)
Revenue
$23,031K
(-66.29%↓ Y/Y)
Proceeds from sale of
fixed assets
$56K
(-42.27%↓ Y/Y)
Repayments on line of credit
$14,722K
(-71.65%↓ Y/Y)
Payments on long-term
debt
$930K
Payment of taxes from
withholding of common stock...
$46K
(-24.59%↓ Y/Y)
Payments on financing
leases
$9K
(-73.53%↓ Y/Y)
Net cash (used in)
provided by operating...
-$7,308K
(-386.14%↓ Y/Y)
Canceled cashflow
$8,050K
Net cash provided by
(used in) investing...
-$5,191K
(-255.55%↓ Y/Y)
Gross profit
$13,330K
(-70.06%↓ Y/Y)
Other (income)
expense
$347K
(17450.00%↑ Y/Y)
Unrealized foreign
currency translation...
$23K
(-88.61%↓ Y/Y)
Interest income
$1K
Canceled cashflow
$56K
Canceled cashflow
$9,701K
Net (loss) income
-$9,413K
(-360.89%↓ Y/Y)
Canceled cashflow
$13,701K
Accounts receivable
$2,520K
(-63.33%↓ Y/Y)
Inventories
$1,980K
(46.78%↑ Y/Y)
Accrued liabilities
-$995K
(-136.01%↓ Y/Y)
Prepaid and other assets
$450K
(229.68%↑ Y/Y)
Distribution agreement
deposit
$5,000K
Purchases of property and
equipment
$247K
(-84.14%↓ Y/Y)
Less cost of sales
$9,701K
(-59.22%↓ Y/Y)
Sales and marketing
$10,368K
(-54.57%↓ Y/Y)
General and
administrative
$6,436K
(-57.12%↓ Y/Y)
Write-off of distribution
agreement deposit
$5,000K
Research and development
$695K
(-31.12%↓ Y/Y)
Interest expense
$542K
(-73.55%↓ Y/Y)
Provision for income taxes
$73K
(-68.26%↓ Y/Y)
Buy us a coffee
Xtant Medical Holdings, Inc. (XTNT)
Xtant Medical Holdings, Inc. (XTNT)